Literature DB >> 17881431

Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro.

Philip Heiser1, Frank Enning, Jürgen-Christian Krieg, Helmut Vedder.   

Abstract

Cytotoxic effects on neuronal as well as on immune cells have been reported for both typical and atypical antipsychotic drugs. We evaluated the effects of different concentrations of a typical (haloperidol) and two atypical (clozapine, olanzapine) antipsychotics on the survival of human neuronal (SH-SY5Y cells) and immune cells (U937 cells) by determining the metabolic activity after 24 h of incubation by the modified tetrazolium method. The dopaminergic neuroblastoma SH-SY5Y and the lymphoma U-937 cell line are well established models for in vitro investigations. To further elucidate possible mechanisms of action we also determined the ATP content in the cultured cells. After experimental treatment, significant effects were detected by Kruskal Wallis test for all treatment conditions. Post-hoc tests (Dunn's method) showed that haloperidol and clozapine at the two highest concentrations (25 and 50 microg/ml) caused a significant decrease of metabolic activity in both cell systems, which was also detectable after treatment with clozapine at a concentration of 12.5 microg/ml in U937 cells. In contrast, olanzapine induced a significant increase in metabolic activity of SH-SY5Y cells at all concentrations except for the concentration of 3.1 microg/ml, whereas the metabolic activity in U937 cells was increased at concentrations of 1.6 and 6.25 microg/ml. For the determination of ATP content, the LD(50) values of the metabolic activity were used, except for olanzapine for which no distinct LD(50) value was available. Significant changes were detected for all treatments and post-hoc tests revealed that haloperidol caused a significant decrease compared to the control condition in both cell systems. These findings suggest that antipsychotic substances of different classes exert differential metabolic effects in both neuronal and immune cell systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881431     DOI: 10.1177/0269881107077221

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  10 in total

1.  Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase.

Authors:  Goro Takami; Miyuki Ota; Akira Nakashima; Yoko S Kaneko; Keiji Mori; Toshiharu Nagatsu; Akira Ota
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

Review 2.  Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients.

Authors:  Richard J Beninger; Tyson W Baker; Matthew M Florczynski; Tomek J Banasikowski
Journal:  Neurotox Res       Date:  2010-04-08       Impact factor: 3.911

3.  Investigation into effects of antipsychotics on ectonucleotidase and adenosine deaminase in zebrafish brain.

Authors:  Kelly Juliana Seibt; Renata da Luz Oliveira; Mauricio Reis Bogo; Mario Roberto Senger; Carla Denise Bonan
Journal:  Fish Physiol Biochem       Date:  2015-07-09       Impact factor: 2.794

Review 4.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

5.  Effect fingerprints of antipsychotic drugs on neural networks in vitro.

Authors:  Philipp Görtz; Uwe Henning; Stephan Theiss; Christian Lange-Asschenfeldt
Journal:  J Neural Transm (Vienna)       Date:  2019-07-18       Impact factor: 3.575

6.  Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine.

Authors:  Ljubica Vucicevic; Maja Misirkic-Marjanovic; Verica Paunovic; Tamara Kravic-Stevovic; Tamara Martinovic; Darko Ciric; Nadja Maric; Sasa Petricevic; Ljubica Harhaji-Trajkovic; Vladimir Bumbasirevic; Vladimir Trajkovic
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

7.  New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.

Authors:  Avia Merenlender-Wagner; Zeev Shemer; Olga Touloumi; Roza Lagoudaki; Eliezer Giladi; Annie Andrieux; Nikolaos C Grigoriadis; Illana Gozes
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

8.  Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation.

Authors:  Jean-Michel Aubry; Michèle Schwald; Eladia Ballmann; Félicien Karege
Journal:  Psychopharmacology (Berl)       Date:  2009-05-14       Impact factor: 4.530

9.  Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine.

Authors:  Abbie G Anderson; Cullen B Gaffy; Joshua R Weseli; Kelly L Gorres
Journal:  Viruses       Date:  2019-05-17       Impact factor: 5.048

10.  Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.

Authors:  Sonja Orlovska-Waast; Ole Köhler-Forsberg; Sophie Wiben Brix; Merete Nordentoft; Daniel Kondziella; Jesper Krogh; Michael Eriksen Benros
Journal:  Mol Psychiatry       Date:  2018-08-16       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.